You are here

Interviews

Edward Kliphuis
31.05.2017

Edward Kliphuis

Investment Director at Merck Ventures

Edward Kliphuis joined the previous biopharma fund MS Ventures in 2014 and transitioned to Investment Director New Businesses. Previously, Edward was at Kempen & Co, a pan-European merchant bank based in Amsterdam, where he was on the Life Sciences Securities team. He was instrumental in the team’s ongoing fundraising efforts for listed European small- and mid-cap biotech companies in over 20 deals in 2012 and 2013. Edward holds an MSc in Biopharmaceutical Sciences from Leiden University, the Netherlands, specializing in pharmacology and science-based business. 

Fellows Institut Guttmann 2017
25.05.2017

Nico Facuri, Enrique Hernández and Sara Hernández

Neoros team. Fellows in d·HEALTH Barcelona 2017 that did their clinical immersion at Institut Guttmann.

Entrevista a Miquel A. Pericàs
26.04.2017

Miquel A. Pericàs

Director of the Barcelona Institute of Science and Technology (BIST) and the Institute of Chemical Research of Catalonia (ICIQ)

Since October 2016, Dr. Pericàs has combined his position as director of the ICIQ with the responsibility of heading up BIST. Before taking on the role as director of the ICIQ in 2000, he was a professor of Organic Chemistry at the University of Barcelona. Pericàs’s research career focused on chemistry and has received Catalan government's Distinction for the Promotion of University Research, the Janssen-Cylag Award from the Spanish Royal Society of Chemistry and the Narcís Monturiol Medal from the Government of Catalonia.

Richard Seabrook
27.03.2017

Richard Seabrook

Senior Advisor and former Head of Business Development at the Wellcome Trust

Dr. Seabrook, PhD, MBA served as Head of Business Development at the Wellcome Trust, responsible for intellectual property management and its transfer, through licensing or new company formation. Seabrook also led the Technology Transfer Division, which aims to add value to basic scientific findings when they can be developed into products. This division reduces the risk, the proof of concept, and makes it attractive to follow-on investors (licensing perspective or financial community).

Zayna Khayat
28.02.2017

Zayna Khayat

Director of MaRS EXCITE program at MaRS Discovery District, Health System Innovation

Khayat works to get healthcare systems to adopt the best technology to improve public health and performance, as well as promoting the new economy of health. She is also an adjunct professor in the Health Sector Strategy stream at the University of Toronto Rotman School of Management. She has 11 years of experience in strategic consulting in the healthcare and life sciences sector.

Susan Bannister
21.02.2017

Susan W. Bannister

Former President and CEO of Massachussetts Life Sciences Center

A world-renowned expert in innovation, she has been called one of the "10 most influential women in biotech" by the Boston Globe and one of the "50 most powerful women in Boston" by Boston Magazine. She is managing partner at Biomedical Innovation Advisors and also President and CEO of Biomedical Growth Strategies. She has been president and CEO of the Massachusetts Life Sciences Center (MLC).